Sign Up to like & get recommendations! 2
Published in 2022 at "ESC Heart Failure"
DOI: 10.1002/ehf2.13842
Abstract: Atrial septal shunt devices might improve hospitalizations and also prognosis in heart failure with increased pulmonary pressures due to left heart diseases. In recent years, atrial shunt devices have been used for the treatment of… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "European Journal of Pain"
DOI: 10.1002/ejp.1066
Abstract: Previous findings suggest that watching sites of experimental and chronic pain can exert an analgesic effect. Our present study investigates whether watching one's back during massage increases the analgesic effect of this treatment in chronic… read more here.
Sign Up to like & get recommendations! 1
Published in 2019 at "Hematological Oncology"
DOI: 10.1002/hon.2695
Abstract: A major revolution in the treatment of chronic lymphocytic leukemia (CLL) began with the approval of ibrutinib, a first‐in‐class oral inhibitor of Bruton tyrosine kinase (BTK), for the treatment of relapsed/refractory (R/R) and/or TP53 mutated… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "Clinical Oral Investigations"
DOI: 10.1007/s00784-017-2154-7
Abstract: ObjectiveChemotherapeutic agents have been widely used as adjuncts for the treatment of chronic periodontitis (CP). This study investigated and compared a desiccant agent as an adjunct to scaling and root planing (SRP) versus SRP alone… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of Contemporary Psychotherapy"
DOI: 10.1007/s10879-017-9362-y
Abstract: Although the psychodynamic literature has examined some of the links between developmental trauma and suicidal thinking and behavior, much of this scholarship focuses on the management of chronic suicidality in the treatment of patients with… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Actas dermo-sifiliograficas"
DOI: 10.1016/j.ad.2016.07.018
Abstract: Omalizumab is a recombinant humanized monoclonal antibody that inhibits immunoglobulin E. It has been approved for the treatment of severe asthma and chronic spontaneous urticaria refractory to other treatments. Its use in the management of… read more here.
Sign Up to like & get recommendations! 1
Published in 2018 at "Actas dermo-sifiliograficas"
DOI: 10.1016/j.ad.2018.08.002
Abstract: Omalizumab is a monoclonal anti-IgE antibody currently used in the treatment of chronic spontaneous urticaria (CSU) as a third-line option in cases refractory to treatment with the licensed dose of the first-line treatment or up… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Annals of vascular surgery"
DOI: 10.1016/j.avsg.2016.08.009
Abstract: BACKGROUND Endovascular intervention is considered the first-line treatment for chronic mesenteric ischemia (CMI) when feasible. Two-vessel revascularization is most definitive when celiac (CA) and superior mesenteric arteries (SMA) are diseased, but single-vessel intervention may be… read more here.
Sign Up to like & get recommendations! 1
Published in 2018 at "Cirugia espanola"
DOI: 10.1016/j.ciresp.2017.09.014
Abstract: INTRODUCTION The treatment of chronic anal fissure (FAC) differs depending on the professional. To come to a consensus, the current situation in Spain should be studied. The aim of this study is to evaluate the… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "Current problems in pediatric and adolescent health care"
DOI: 10.1016/j.cppeds.2017.06.006
Abstract: Pediatric chronic pain is a challenging entity to evaluate and treat as it encompasses a wide variety of presentations often with overlapping psychosocial implications. Chronic pain may have significant effects upon a child's involvement in… read more here.